Alvim et al. recently published further data on vascular-targeted PDT (WST 11) in combination with a PD1 inhibitor and OX40 in a mouse model with allografted MB-49 upper tract urothelial carcinoma cells. Here, TNFRSF4 is linked to renal pelvis/ureter urothelial carcinoma.